DP&S and Parker Waichman LLP help keep cancer drug suit alive!
Congratulations to firm client Parker Waichman LLP on securing a denial of a motion to dismiss filed by Defendant Novartis Pharmaceuticals Corp. in a case pending in the District of New Mexico alleging that Novartis hid serious side effects of its blood cancer drug Tasigna. Novartis argued that the plaintiff failed to allege the exact […]
DP&S and Parker Waichman LLP help keep cancer drug suit alive! Read More »